isomethyleugenol has been researched along with Diabetes Mellitus, Type 1 in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 11 (64.71) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, G; Li, J; Li, X; Luo, S; Pang, H; Shi, X; Sun, X; Wang, Y; Xie, Z; Xu, L; Zhou, J; Zhou, Y; Zhou, Z | 1 |
| Clark, P; Dong, F; Fouts, A; Gottlieb, P; Herold, KC; Pyle, L; Simmons, KM; Steck, AK; Usmani-Brown, S; Yu, L | 1 |
| Chen, N; Chu, S; Gao, Y; Li, J; Li, L; Zhang, L; Zhang, Z | 1 |
| Li, H; Liu, XY | 1 |
| Allen, TJ; Cooper, ME; El-Osta, A; Jandeleit-Dahm, KAM; Thomas, MC; Watson, AMD | 1 |
| Alves-Wagner, AB; Correa-Giannella, ML; Esteves, JV; Giannella-Neto, D; Machado, UF; Okamoto, MM; Yonamine, CY | 1 |
| Abdollahi, M; Das, S; Jia, Y; Lanting, L; Natarajan, R; Oh, HJ; Reddy, MA; Wang, M; Yuan, H; Zhang, E | 1 |
| Mizutani, S; Ogawa, Y; Sawada, N; Takizawa, F | 1 |
| Bomsztyk, K; Denisenko, O; Komers, R; Mar, D; Oyama, TT; Xu, B | 1 |
| Cui, P; Guo, Q; Han, H; Li, C; Li, Q; Li, X; Liu, S; Sun, G | 1 |
| Araki, Y; Mimura, T | 1 |
| Guo, F; Li, X; Liu, Y; Xu, Y; Zhang, B; Zhao, Y; Zheng, Q | 1 |
| Jayaraman, S | 1 |
| Bartáková, V; Bělobrádková, J; Jurajda, M; Kaňková, K; Klepárník, M; Krusová, D; Kuricová, K; Malúšková, D; Mužík, J; Olšovský, J; Pácal, L; Pavlík, T; Rehořová, J; Stěpánková, S; Svojanovský, J; Tanhäuserová, V; Tomandl, J | 1 |
| Deal, CL | 1 |
| Arima, T; Bonthron, DT; Hayashizaki, Y; Hermann, R; Judson, H; Kamimura, K; Kamiya, M; Kusakabe, M; Muramatsu, M; Okazaki, Y; Satomura, K; Takada, S; Takagi, N; Wake, N | 1 |
| Okamoto, H | 1 |
4 review(s) available for isomethyleugenol and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Metabolic Karma-The Atherogenic Legacy of Diabetes: The 2017 Edwin Bierman Award Lecture.
Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Epigenesis, Genetic; Glycation End Products, Advanced; Histone Code; Humans; Hyperglycemia; Methylation; Oxidative Stress | 2018 |
The Histone Modification Code in the Pathogenesis of Autoimmune Diseases.
Topics: Animals; Arthritis, Rheumatoid; Autoantibodies; Autoimmune Diseases; Autoimmunity; Catalysis; Chromatin; Diabetes Mellitus, Type 1; DNA; DNA Methylation; Epigenesis, Genetic; Genetic Predisposition to Disease; Histone Code; Histones; Humans; Inflammation; Lupus Erythematosus, Systemic; Methylation; Phenotype; Phosphorylation | 2017 |
Epigenetics of autoimmune diabetes.
Topics: Acetylation; Animals; Chromatin Assembly and Disassembly; Diabetes Mellitus, Type 1; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Histones; Humans; Methylation; Mice; Models, Biological; RNA, Untranslated | 2011 |
Parental genomic imprinting.
Topics: Angelman Syndrome; Animals; Beckwith-Wiedemann Syndrome; Diabetes Mellitus, Type 1; Genomic Imprinting; Humans; Insulin-Like Growth Factor II; Kidney Neoplasms; Methylation; Mice; Muscle Proteins; Neoplasms; Prader-Willi Syndrome; RNA, Long Noncoding; RNA, Untranslated; Transcription, Genetic; Wilms Tumor | 1995 |
13 other study(ies) available for isomethyleugenol and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
The m6A methylation profiles of immune cells in type 1 diabetes mellitus.
Topics: Autoimmune Diseases; Diabetes Mellitus, Type 1; Gene Ontology; Humans; Methylation; Methyltransferases; Protein Processing, Post-Translational; RNA-Binding Proteins | 2022 |
Unmethylated Insulin as an Adjunctive Marker of Beta Cell Death and Progression to Type 1 Diabetes in Participants at Risk for Diabetes.
Topics: Adolescent; Age of Onset; Autoantibodies; Biomarkers; Cell Death; Child; Diabetes Mellitus, Type 1; Disease Progression; Disease Susceptibility; Female; Humans; Insulin; Insulin-Secreting Cells; Male; Methylation; Risk; Young Adult | 2019 |
Ginsenoside Rg1 protects mice against streptozotocin-induced type 1 diabetic by modulating the NLRP3 and Keap1/Nrf2/HO-1 pathways.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Glucose; Diabetes Mellitus, Type 1; Ginsenosides; Heme Oxygenase-1; Histones; Kelch-Like ECH-Associated Protein 1; Liver; Male; Membrane Proteins; Methylation; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; NLR Family, Pyrin Domain-Containing 3 Protein; Pancreas; Signal Transduction; Streptozocin | 2020 |
Reduced Histone H3 Lysine 9 Methylation Contributes to the Pathogenesis of Latent Autoimmune Diabetes in Adults via Regulation of SUV39H2 and KDM4C.
Topics: Adult; Case-Control Studies; CD4-Positive T-Lymphocytes; Diabetes Mellitus, Type 1; Down-Regulation; Female; Gene Expression Profiling; Gene Expression Regulation, Enzymologic; Glycated Hemoglobin; Glycosylation; Histone-Lysine N-Methyltransferase; Histones; Humans; Jumonji Domain-Containing Histone Demethylases; Lysine; Male; Methylation; Middle Aged | 2017 |
Diabetes induces tri-methylation at lysine 9 of histone 3 at Slc2a4 gene in skeletal muscle: A new target to improve glycemic control.
Topics: Animals; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Models, Animal; Epigenesis, Genetic; Glucose Transporter Type 4; Histones; Humans; Insulin; Lysine; Male; Methylation; Mice; Muscle, Skeletal; Promoter Regions, Genetic; Rats; Resveratrol | 2019 |
Dysregulation of histone H3 lysine 27 trimethylation in transforming growth factor-β1-induced gene expression in mesangial cells and diabetic kidney.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Expression Regulation; Histones; Humans; Injections, Intraperitoneal; Lysine; Male; Mesangial Cells; Methylation; Mice; Mice, Inbred C57BL; Rats; Rats, Sprague-Dawley; Streptozocin; Transforming Growth Factor beta1 | 2019 |
Glucose-independent persistence of PAI-1 gene expression and H3K4 tri-methylation in type 1 diabetic mouse endothelium: implication in metabolic memory.
Topics: Animals; Cells, Cultured; Chromatin Assembly and Disassembly; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Endothelial Cells; Epigenesis, Genetic; Gene Expression; Glucose; Histones; Humans; Male; Methylation; Mice; Mice, Inbred C57BL; Promoter Regions, Genetic; RNA, Messenger; Serpin E2 | 2013 |
Epigenetic changes in renal genes dysregulated in mouse and rat models of type 1 diabetes.
Topics: Animals; Chemokine CCL2; Chromatin Immunoprecipitation; Cyclooxygenase 2; Cyclophilins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Epigenesis, Genetic; Gene Expression Regulation; Histone Demethylases; Kidney; Laminin; Methylation; Mice; Rats; RNA Polymerase II; S100 Calcium-Binding Protein A4; S100 Proteins; Vimentin | 2013 |
Involvement of Histone Lysine Methylation in p21 Gene Expression in Rat Kidney In Vivo and Rat Mesangial Cells In Vitro under Diabetic Conditions.
Topics: Animals; Antibodies; Blotting, Western; Cyclin-Dependent Kinase Inhibitor p21; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Gene Expression Regulation; Glucose; Histone Code; Histone-Lysine N-Methyltransferase; In Vitro Techniques; Kidney Glomerulus; Lysine; Male; Mesangial Cells; Methylation; Promoter Regions, Genetic; Rats; Rats, Wistar; Transforming Growth Factor beta1 | 2016 |
Induction of Foxp3 demethylation increases regulatory CD4+CD25+ T cells and prevents the occurrence of diabetes in mice.
Topics: Animals; Azacitidine; Base Sequence; CD4-Positive T-Lymphocytes; Decitabine; Diabetes Mellitus, Type 1; Female; Forkhead Transcription Factors; Humans; Interleukin-2 Receptor alpha Subunit; Lymphocyte Activation; Male; Methylation; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Molecular Sequence Data; T-Lymphocytes, Regulatory; Thymus Gland; Treatment Outcome | 2009 |
ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis.
Topics: Adult; Aged; Amidohydrolases; Arginine; Cross-Sectional Studies; Czech Republic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Female; Follow-Up Studies; Humans; Male; Methylation; Middle Aged; Multivariate Analysis; Polymorphism, Single Nucleotide; Predictive Value of Tests; Prognosis; Reproducibility of Results; Risk Factors | 2012 |
The cell cycle control gene ZAC/PLAGL1 is imprinted--a strong candidate gene for transient neonatal diabetes.
Topics: Cell Cycle; Cell Cycle Proteins; Chromosomes, Human, Pair 6; Contig Mapping; CpG Islands; Diabetes Mellitus, Type 1; DNA-Binding Proteins; Female; Genes, Tumor Suppressor; Genomic Imprinting; Humans; Infant, Newborn; Methylation; Polymerase Chain Reaction; Restriction Mapping; RNA-Binding Proteins; Transcription Factors; Tumor Suppressor Proteins; Zinc Fingers | 2000 |
The role of poly(ADP-ribose) synthetase in the development of insulin-dependent diabetes and islet B-cell regeneration.
Topics: Alloxan; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; DNA Repair; DNA Replication; Islets of Langerhans; Methylation; NAD; NAD+ Nucleosidase; Poly(ADP-ribose) Polymerases; Streptozocin | 1985 |